Cardiovascular Diseases

Supporting Cardiovascular Diseases Research

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, claiming approximately 17.9 million lives each year according to the World Health Organization (WHO).

These diseases, which include conditions such as coronary artery disease, cerebrovascular disease, and rheumatic heart disease, account for more than 30% of all global deaths. To combat this, the pharmaceutical industry invests heavily in cardiovascular research, with substantial funds allocated annually to develop new treatments and therapies aimed at reducing the global impact of these diseases^1,2​.

Sampled provides crucial support to cardiovascular researchers through a range of specialized services designed to streamline and enhance various stages of the research pipeline. Our services include efficient cryogenic storage, which ensures the preservation of valuable biological samples under optimal conditions, thereby maintaining their integrity for subsequent analysis. Additionally, Sampled offers advanced genomic and transcriptomic analysis using cutting-edge technologies such as next-generation sequencing and microarrays. These services enable researchers to gain comprehensive insights into the genetic underpinnings of cardiovascular diseases, identify potential biomarkers, and validate therapeutic targets. By outsourcing these critical components to Sampled, researchers can focus on their core research activities, accelerate their discovery and development processes, and ultimately contribute to the advancement of cardiovascular medicine^2,3.